Abstract: A novel monoclonal antibody that specifically recognizes phosphatidylinositol-3,4-biphosphate (PI-3,4-P2) but does not cross-react with structurally similar phospholipid antigens is advantageous for PI-3,4-P2-specific immunoassay. The gene in the variable regions of the monoclonal antibody has been identified, which enables producing recombinant antibodies.
Type:
Grant
Filed:
March 3, 2000
Date of Patent:
March 23, 2004
Assignees:
Yasuhisa Fukui, Medical & Biological Laboratories, Co., Ltd.